BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22982404)

  • 1. Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.
    Dai MS; Vassaux G; Xu M; You RI; Hsieh YF; Ouisse LH; Lo KY; Sytwu HK; Chao TY
    Vaccine; 2012 Nov; 30(48):6903-11. PubMed ID: 22982404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo.
    Nitcheu-Tefit J; Dai MS; Critchley-Thorne RJ; Ramirez-Jimenez F; Xu M; Conchon S; Ferry N; Stauss HJ; Vassaux G
    J Immunol; 2007 Aug; 179(3):1532-41. PubMed ID: 17641019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine.
    Sun X; Provoda C; Lee KD
    J Control Release; 2010 Dec; 148(2):219-25. PubMed ID: 20620181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.
    Radford KJ; Higgins DE; Pasquini S; Cheadle EJ; Carta L; Jackson AM; Lemoine NR; Vassaux G
    Gene Ther; 2002 Nov; 9(21):1455-63. PubMed ID: 12378408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun.
    Fensterle J; Grode L; Hess J; Kaufmann SH
    J Immunol; 1999 Oct; 163(8):4510-8. PubMed ID: 10510394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
    Peng X; Treml J; Paterson Y
    Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer.
    Lin T; Liang S; Meng F; Han Q; Guo C; Sun L; Chen Y; Liu Z; Yu Z; Xie H; Ding J; Fan D
    Clin Exp Immunol; 2006 May; 144(2):319-25. PubMed ID: 16634806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Anti-Treg Vaccination Targeting Foxp3 Efficiently Decreases Regulatory T Cells in Mice.
    Mousavi Niri N; Memarnejadian A; Pilehvar-Soltanahmadi Y; Agha Sadeghi M; Mahdavi M; Kheshtchin N; Arab S; Namdar A; Jadidi F; Zarghami N; Hajati J
    J Immunother; 2016 Sep; 39(7):269-75. PubMed ID: 27404943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
    Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
    BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
    Mandal M; Lee KD
    Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect.
    Song S; Liu C; Wang J; Zhang Y; You H; Wang Y; Liu F; Sun S
    Vaccine; 2009 Feb; 27(7):1111-8. PubMed ID: 19100302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
    Hung CF; Calizo R; Tsai YC; He L; Wu TC
    Vaccine; 2007 Jan; 25(1):127-35. PubMed ID: 16930783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.
    Bissa M; Illiano E; Pacchioni S; Paolini F; Zanotto C; De Giuli Morghen C; Massa S; Franconi R; Radaelli A; Venuti A
    J Transl Med; 2015 Mar; 13():80. PubMed ID: 25763880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
    J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.
    Dai MS; Nitcheu-Tefit J; Alcock S; Ramirez-Jimenez F; Chao TY; Baril P; Rocha M; Brett SJ; Stauss HJ; Vassaux G
    J Immunother; 2009 Oct; 32(8):845-55. PubMed ID: 19752749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.